Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 9, 2017Oncology Research Featuring Preclinical and Clinical Cancer TherapeuticsOpen Access

Long Noncoding RNA PVT1 Facilitates Cervical Cancer Progression via Negative Regulating of miR-424

View Full Paper
Ask AI
Bookmark
Share

Authors

YGYali GaoShenZhen People’s HospitalZZZishen ZhaoZhengzhou UniversityMZMingyun ZhangQingdao University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Gao et al. (2017) studied this question.

synapsesocial.com/papers/69dec4575e217d93a555862fhttps://doi.org/10.3727/096504017x14881559833562
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Increased expression of long non-coding RNA XIST predicts favorable prognosis of cervical squamous cell carcinoma subsequent to definitive chemoradiation therapy2016 · 43 citations
  2. 2The Emerging Roles of Long Noncoding RNA ROR (lincRNA-ROR) and its Possible Mechanisms in Human Cancers2016 · 129 citations
  3. 3Curcumin as a multifaceted compound against human papilloma virus infection and cervical cancers: A review of chemistry, cellular, molecular, and preclinical features2016 · 194 citations
  4. 4Transcriptional profiling identifies the long noncoding RNA plasmacytoma variant translocation (PVT1) as a novel regulator of the asthmatic phenotype in human airway smooth muscle2016 · 106 citations
  5. 5miR-424 acts as a tumor radiosensitizer by targeting aprataxin in cervical cancer2016 · 40 citations